Affordable healthcare will require drugmakers to make better drugs more efficiently
Sanjay Gade and Deepak Jain, Ranbaxy Laboratories Ltd.
If the debate that culminated in passage of national healthcare reform in the U.S. is any indication of what is ahead for pharmaceutical manufacturers, they should ready themselves for battle. Implementation of the sweeping measure puts the onus on drugmakers to minimize waste and boost production of active pharmaceutical ingredients (APIs) and finished products, ensuring affordable healthcare for everyone....
This information is only available to Gold members.
Forgot your user ID or password? Click here to have it sent to you.
Not a member yet?
UPGRADE now to full archive accces and you will receive:
A discount on full delegate pass to ChemInnovations.